- Home
- BKU vs ARWR Comparison
BKU vs ARWR Comparison
Compare BKU & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- ARWR
- Stock Information
- Founded
- BKU 2009
- ARWR 2003
- Country
- BKU United States
- ARWR United States
- Employees
- BKU N/A
- ARWR N/A
- Industry
- BKU Savings Institutions
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- ARWR Health Care
- Exchange
- BKU Nasdaq
- ARWR Nasdaq
- Market Cap
- BKU 2.8B
- ARWR 2.4B
- IPO Year
- BKU 2011
- ARWR 1993
- Fundamental
- Price
- BKU $39.79
- ARWR $19.56
- Analyst Decision
- BKU Hold
- ARWR Buy
- Analyst Count
- BKU 10
- ARWR 11
- Target Price
- BKU $41.30
- ARWR $43.33
- AVG Volume (30 Days)
- BKU 740.4K
- ARWR 1.5M
- Earning Date
- BKU 01-22-2025
- ARWR 02-04-2025
- Dividend Yield
- BKU 2.91%
- ARWR N/A
- EPS Growth
- BKU N/A
- ARWR N/A
- EPS
- BKU 2.44
- ARWR N/A
- Revenue
- BKU $919,935,000.00
- ARWR $3,551,000.00
- Revenue This Year
- BKU N/A
- ARWR $3,402.96
- Revenue Next Year
- BKU $7.23
- ARWR $123.96
- P/E Ratio
- BKU $16.30
- ARWR N/A
- Revenue Growth
- BKU 3.57
- ARWR N/A
- 52 Week Low
- BKU $24.34
- ARWR $17.05
- 52 Week High
- BKU $44.45
- ARWR $36.72
- Technical
- Relative Strength Index (RSI)
- BKU 55.07
- ARWR 47.89
- Support Level
- BKU $39.04
- ARWR $17.75
- Resistance Level
- BKU $40.85
- ARWR $19.19
- Average True Range (ATR)
- BKU 1.03
- ARWR 1.04
- MACD
- BKU 0.21
- ARWR 0.04
- Stochastic Oscillator
- BKU 76.70
- ARWR 59.74
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located primarily throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.